Article ID Journal Published Year Pages File Type
2772019 Seminars in Arthritis and Rheumatism 2006 6 Pages PDF
Abstract
Clarithromycin, a macrolide antibiotic, led to clinical improvement in patients with UCTD. Efficacy and safety data support further investigation of macrolide antibiotic use as a primary or adjunctive treatment in various connective tissue diseases.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Preview
Open-Label Study of Clarithromycin in Patients with Undifferentiated Connective Tissue Disease
Authors
, , , ,